OTCPK:RMTN

Stock Analysis Report

Executive Summary

Rocky Mountain Ayre, Inc., through its subsidiaries, engages in food and hospitality, manufacturing, medical marijuana, and retail businesses.

Snowflake

Fundamentals

Adequate balance sheet with weak fundamentals.

Risks

  • Rocky Mountain Ayre's last earnings update was 5915 days ago.
  • Rocky Mountain Ayre is not covered by any analysts.

Share Price & News

How has Rocky Mountain Ayre's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

RMTN

0.008%

US Healthcare

-0.2%

US Market


1 Year Return

n/a

RMTN

-9.0%

US Healthcare

1.1%

US Market

No trading data on RMTN.

No trading data on RMTN.


Share holder returns

RMTNIndustryMarket
7 Day0%0.008%-0.2%
30 Day0%-0.8%2.5%
90 Day0%-1.5%1.6%
1 Yearn/a-7.6%-9.0%3.4%1.1%
3 Year-93.8%-93.8%29.6%24.4%45.2%35.8%
5 Year-90.0%-90.0%66.2%56.2%62.6%44.8%

Price Volatility Vs. Market

How volatile is Rocky Mountain Ayre's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Rocky Mountain Ayre undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether Rocky Mountain Ayre is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Rocky Mountain Ayre has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Examine Rocky Mountain Ayre's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Rocky Mountain Ayre regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Rocky Mountain Ayre expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

10.9%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Rocky Mountain Ayre has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Rocky Mountain Ayre performed over the past 5 years?

0.1%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Rocky Mountain Ayre has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

Financial Health

How is Rocky Mountain Ayre's financial position?


In this section we usually analyse Rocky Mountain Ayre's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Rocky Mountain Ayre has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of RMTN’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Rocky Mountain Ayre's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is Rocky Mountain Ayre's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Rocky Mountain Ayre's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Rocky Mountain Ayre's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Rocky Mountain Ayre has not reported any payouts.

Unable to verify if Rocky Mountain Ayre's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Rocky Mountain Ayre has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Rocky Mountain Ayre's salary, the management and board of directors tenure and is there insider trading?

16.3yrs

Average board tenure


CEO

Greg Sullivan 0

1.8yrs

Tenure

0

Dr. Gregory Sullivan, also known as Greg, has been Chief Executive Officer at Rocky Mountain Ayre, Inc. since October 2017. Dr. Sullivan over 25 years experience producing scientific opportunities. He serv ...


Board Age and Tenure

16.3yrs

Average Tenure

The average tenure for the Rocky Mountain Ayre board of directors is over 10 years, this suggests they are a seasoned and experienced board.


Insider Trading

No 3 month open market individual insider trading information.


Management Team

  • Greg Sullivan

    CEO & Director

    • Tenure: 1.8yrs
  • Timothy Ayre

    President & CFO

    • Tenure: 0yrs

Board Members

  • Ronald Potts (71yo)

    Chairman of the Board

    • Tenure: 16.3yrs
  • Lewis Bivens (73yo)

    Director

    • Tenure: 16.8yrs
  • A. Gutpa

    Director

    • Tenure: 0yrs
  • Greg Sullivan

    CEO & Director

    • Tenure: 1.8yrs

Company Information

Rocky Mountain Ayre, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Rocky Mountain Ayre, Inc.
  • Ticker: RMTN
  • Exchange: OTCPK
  • Founded: 1999
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$5.825m
  • Shares outstanding: 582.49m
  • Website: https://www.rockymountainayre.com

Location

  • Rocky Mountain Ayre, Inc.
  • 3500 South Dupont Highway
  • Dover
  • Delaware
  • 19901
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
RMTNOTCPK (Pink Sheets LLC)YesCommon StockUSUSDOct 2002

Biography

Rocky Mountain Ayre, Inc., through its subsidiaries, engages in food and hospitality, manufacturing, medical marijuana, and retail businesses. It operates a restaurant located in Agawam, Massachusetts. The ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/20 00:12
End of Day Share Price2019/05/22 00:00
Earnings2003/03/31
Annual Earnings2002/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.